All stock lists
Wave Life Sciences, Inc. (NASDAQ:WVE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.21+0.03 (+0.94%)
Insider Score
––Not scored
WVE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
WVE Stock Insider Trading Activity
WVE stock’s insider trading shows 4 sales on the open market for an estimated $135.07K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wagner Heidi L Director | Award | 10,700 | — | — | 23.8% | 55,630 | Oct 5, 2026 | — | Form 4 |
| TAKANASHI KEN Director | Award | 10,700 | — | — | 53.3% | 30,779 | Oct 5, 2026 | — | Form 4 |
| CORRIGAN MARK Director | Award | 10,700 | — | — | 37.1% | 39,515 | Oct 5, 2026 | — | Form 4 |
| Rawcliffe Adrian Director | Award | 10,700 | — | — | New | 10,700 | Oct 5, 2026 | — | Form 4 |
| Verdine Gregory L. Director | Award | 10,700 | — | — | 5.6% | 200,917 | Oct 5, 2026 | — | Form 4 |
| HENRY CHRISTIAN O Director | Award | 10,700 | — | — | 84.3% | 23,400 | Oct 5, 2026 | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. Director | Award | 10,700 | — | — | 37.1% | 39,515 | Oct 5, 2026 | — | Form 4 |
| Tan Aik Na Director | Award | 10,700 | — | — | 42.9% | 35,668 | Oct 5, 2026 | — | Form 4 |
| Rawcliffe Adrian Director | Sell | 12,700 | $5.29 | $67.18K | 100% | 0 | Aug 12, 2026 | — | Form 4 |
| Wagner Heidi L Director | Sell | 7,000 | $6.01 | $42.07K | 13.5% | 44,930 | Aug 11, 2026 | — | Form 4 |
| TAKANASHI KEN Director | Sell | 3,864 | $6.01 | $23.22K | 16.1% | 20,079 | Aug 11, 2026 | — | Form 4 |
| Tan Aik Na Director | Sell | 432 | $6.01 | $2.60K | 1.7% | 24,968 | Aug 11, 2026 | — | Form 4 |
| Wagner Heidi L Director | Option exercise | 7,000 | $5.97 | $41.79K | 15.6% | 51,930 | Aug 11, 2026 | — | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. Director | Buy | 971,091 | $6.50 | $6.31M | 3.7% | 26,975,505 | Mar 30, 2026 | CBig BuyDilution | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. Director | Buy | 2,495,623 | $6.43 | $16.05M | 10.6% | 26,004,414 | Mar 27, 2026 | CBig BuyDilution | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. Director | Buy | 4,954,558 | $6.06 | $30.02M | 27.2% | 23,157,567 | Mar 26, 2026 | CBig BuyDilution | Form 4 |
| RA CAPITAL MANAGEMENT, L.P. Director | Buy | 351,224 | $6.38 | $2.24M | 1.5% | 23,508,791 | Mar 26, 2026 | CBig BuyDilution | Form 4 |
| TAKANASHI KEN Director | Converted | 3,901,348 | — | — | 68.4% | 9,606,408 | Mar 23, 2026 | — | Form 4 |
| Francis Chris Other | Sell | 15,294 | $15.00 | $229.41K | 19.8% | 61,867 | Feb 26, 2026 | — | Form 4 |
| Francis Chris Other | Option exercise | 15,294 | $4.75 | $72.65K | 24.7% | 77,161 | Feb 26, 2026 | — | Form 4 |
| Francis Chris Other | Sell | 17,900 | $15.09 | $270.11K | 22.4% | 61,867 | Feb 26, 2026 | — | Form 4 |
| Francis Chris Other | Option exercise | 17,900 | $3.87 | $69.27K | 28.9% | 79,767 | Feb 26, 2026 | — | Form 4 |
| BOLNO PAUL CEO | Sell | 10,480 | $13.45 | $140.96K | 3.7% | 275,520 | Feb 9, 2026 | — | Form 4 |
| Francis Chris Other | Sell | 1,883 | $13.45 | $25.33K | 3.0% | 61,867 | Feb 9, 2026 | — | Form 4 |
| Vargeese Chandra Other | Sell | 3,228 | $13.45 | $43.42K | 0.8% | 408,246 | Feb 9, 2026 | — | Form 4 |
| Moran Kyle CFO | Sell | 3,588 | $13.45 | $48.26K | 2.6% | 134,385 | Feb 9, 2026 | — | Form 4 |
| Vargeese Chandra Other | Award | 45,625 | — | — | 12.5% | 411,474 | Feb 5, 2026 | — | Form 4 |
| Moran Kyle CFO | Award | 45,625 | — | — | 49.4% | 137,973 | Feb 5, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.